Good morning, one and all. Damian Garde here, filling in for Ed Silverman at Pharmalot’s satellite campus. It is, as you undoubtedly know, the end of yet another working week, which of course means all the assorted indignities of a laboring life will soon fade into the weekend. As always, we hope you have plans to make the most of your reprieve, however brief. In the meantime, please find a few tidbits to get you started this fine Friday. And if you hear anything that raises your eyebrow, do let us know.

Sanofi (SNY) is replacing CEO Olivier Brandicourt with an executive from Novartis (NVS), Reuters reports. On Sept. 1, Novartis’s Paul Hudson will take over the French drug maker. Hudson, who joined Novartis in 2016, has led the Swiss company’s pharmaceutical division. Brandicourt will retire after four years in charge of Sanofi.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy